Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

(2016) Mae Zakhour et al.   GYNECOLOGIC ONCOLOGY

HGVS Recommendations for the Description of Sequence Variants: 2016 Update

(2016) Johan T. den Dunnen et al.   HUMAN MUTATION

Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer

(2016) Karin Kast et al.   JOURNAL OF MEDICAL GENETICS

The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition

(2016) Naruto Taira et al.   Breast Cancer

Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project

(2015) Megumi Hori et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea

(2015) Se Ik Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium

(2015) Seigo Nakamura et al.   Public Health Genomics

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis

(2014) Esther Molina-Montes et al.   BREAST

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

(2014) Xinglei Chai et al.   BREAST CANCER RESEARCH AND TREATMENT

US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

(2014) Nadia Howlader et al.   JNCI-Journal of the National Cancer Institute

Prevalence and differentiation of hereditary breast and ovarian cancers in Japan

(2013) Seigo Nakamura et al.   Breast Cancer

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Korean Hereditary Breast Cancer (KOHBRA) Study: Protocols and Interim Report

(2011) Sang Ah Han et al.   CLINICAL ONCOLOGY

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

(2010) Kokichi Sugano et al.   CANCER SCIENCE

Risk reducing mastectomy: outcomes in 10 European centres

(2008) D G R Evans et al.   JOURNAL OF MEDICAL GENETICS